Divis Pharmaceuticals
- All
- News
-
Pharma Firm, India's Best-Performing Stock, Sees Wave of Optimistic Calls
In just about two weeks, at least four brokerages have raised their price targets on the shares of Divi's Laboratories -- one of the top producers of active pharmaceutical ingredients
-
Divi's Laboratories Slumps Over 30% In Just Two Days Over FDA Concerns
The Vizag plant is one of the biggest plants for Divi's. The company manufactures active pharmaceutical ingredients (APIs) and intermediates for generics among others at the Vizag manufacturing plant.
-
Divi's Labs Gets 5 Observations From USFDA For Vizag Plant
The company manufactures active pharmaceutical ingredients (APIs) and intermediates for generics among others at the manufacturing plant.
-
Divis Laboratories Q3 Net Up Nearly 12% at Rs 246 Crore
Pharmaceuticals firm Divis Laboratories on Friday reported an 11.77 per cent rise in standalone net profit at Rs 246.56 crore for the quarter ended December 31, 2015.
-
Pharma Shares Gain as Government Curbs Regulator's Power
NPPA had capped prices of 108 non-essential drugs in July to improve its affordability, but the decision was greeted with protests and has been challenged in courts in India as prices of generic drugs are already low in India compared with other markets.
-
Andhra Pradesh pollution board directs 12 pharma units to close operations
The Andhra Pradesh Pollution Control Board today ordered closure of 12 manufacturing units of different pharma companies, including Aurobindo Pharma, around the city for allegedly violating pollution norms. According to a Board's release, the notices have been issued to the facilities to stop all industrial activities with effect from July 23 to c...
-
Pharma Firm, India's Best-Performing Stock, Sees Wave of Optimistic Calls
In just about two weeks, at least four brokerages have raised their price targets on the shares of Divi's Laboratories -- one of the top producers of active pharmaceutical ingredients
-
Divi's Laboratories Slumps Over 30% In Just Two Days Over FDA Concerns
The Vizag plant is one of the biggest plants for Divi's. The company manufactures active pharmaceutical ingredients (APIs) and intermediates for generics among others at the Vizag manufacturing plant.
-
Divi's Labs Gets 5 Observations From USFDA For Vizag Plant
The company manufactures active pharmaceutical ingredients (APIs) and intermediates for generics among others at the manufacturing plant.
-
Divis Laboratories Q3 Net Up Nearly 12% at Rs 246 Crore
Pharmaceuticals firm Divis Laboratories on Friday reported an 11.77 per cent rise in standalone net profit at Rs 246.56 crore for the quarter ended December 31, 2015.
-
Pharma Shares Gain as Government Curbs Regulator's Power
NPPA had capped prices of 108 non-essential drugs in July to improve its affordability, but the decision was greeted with protests and has been challenged in courts in India as prices of generic drugs are already low in India compared with other markets.
-
Andhra Pradesh pollution board directs 12 pharma units to close operations
The Andhra Pradesh Pollution Control Board today ordered closure of 12 manufacturing units of different pharma companies, including Aurobindo Pharma, around the city for allegedly violating pollution norms. According to a Board's release, the notices have been issued to the facilities to stop all industrial activities with effect from July 23 to c...
